Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Istodax (romidepsin)
pCPA File Number:
20815
Negotiation Status:
Concluded with an LOI
Indication(s):
Peripheral T-Cell Lymphoma
Sponsor/Manufacturer:
Celgene Inc.
CADTH Project Number:
pCODR 10048
pCPA Engagement Letter Issued:
2015-06-02
Negotiation Process Concluded:
2015-09-16